← Back to Search

Behavioural Intervention

Neck Vibration Therapy for Chronic Cough

N/A

Recruiting

Led By Stephanie Misono

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cough visual analogue scale (VAS): Rating of 30 or greater on a 0-100 cough severity scale

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 weeks

Awards & highlights

Study Summary

This trial will test whether a vibrating device placed on the neck can help people with chronic cough when no other cause can be found.

Who is the study for?

This trial is for English-speaking adults aged 18-88 who have been coughing for more than 8 weeks and rate their cough severity at 30 or higher on a scale of 0 to 100. Participants must be able to give informed consent and fill out questionnaires by themselves. People with electronic implants, no wifi access, contraindications to the device used in the study, or those currently in speech therapy for cough cannot join.Check my eligibility

What is being tested?

The study is examining how non-invasive vibrotactile stimulation (VTS) of the larynx affects people with unexplained chronic cough. Researchers want to see if this treatment can reduce the severity of symptoms.See study design

What are the potential side effects?

While specific side effects are not listed, VTS is generally considered safe but may potentially cause discomfort at the site of stimulation or an increase in coughing during adjustment to the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cough severity is rated 30 or higher on a scale of 0-100.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assess usability of VTS device

Impact of VTS on cough symptoms

Trial Design

1Treatment groups

Experimental Treatment

Group I: Vibrotactile StimulationExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Vibrotactile Stimulation

2016

N/A

~10

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,380 Previous Clinical Trials

1,588,685 Total Patients Enrolled

Stephanie MisonoPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant selection criterion for this research project limited to adults over a certain age?

"In accordance with the enrollment requirements, this trial is open to individuals aged 18-88."

Answered by AI

How many participants have been enrolled in this clinical trial so far?

"Affirmative. As outlined on clinicaltrials.gov, this medical trial is still recruiting participants after first being made available to the public in July 2021. It has since been modified as recently as March 2022 and requires 60 individuals from one healthcare site."

Answered by AI

Does this trial have open enrollment for participants?

"Affirmative. According to information on clinicaltrials.gov, this scientific investigation is actively recruiting participants. It was published in July 13th 2021 and has been updated as recently as March 9th 2022; the study requires 60 individuals from a single medical facility."

Answered by AI

What criteria must an individual meet to be eligible for participation in this experiment?

"This medical trial seeks 60 participants with a persistent cough between 18 and 88 years old. For inclusion in this study, prospective subjects must meet the following conditions: be aged 18-88; have had a coughing fit for 8 weeks or more; report at least 30 points on a 0 to 100 point scale of severity when asked about their coughs; consenting adults capable of filling out questionnaires autonomously as well as being able to comprehend English language instructions."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Stimulation of the Larynx to Treat Unexplained Chronic Cough

2021. "Stimulation of the Larynx to Treat Unexplained Chronic Cough". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05273190.